Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway
Naoki Inui, Satoshi Sakai, Masatoshi Kitagawa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6107-6107
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Qianru Mei, Zhe Liu, He Zuo, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 210
TGF-β signaling: critical nexus of fibrogenesis and cancer
Anna O. Giarratana, Conor M. Prendergast, Mary Salvatore, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Qing Yue, Yu Song, Zi Liu, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4922-4922
Open Access | Times Cited: 55
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Yiman Zhai, Tingyu Wang, Yunmei Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8011-8011
Open Access | Times Cited: 38
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Sang-Ryul Cha, Jimin Jang, Sung‐Min Park, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 36
Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis
Weiming Zhao, Lan Wang, Yaxuan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8749-8749
Open Access | Times Cited: 27
The mitigating effect of para‐hydroxycinnamic acid in bleomycin‐induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways
Zeena Ayad Hussein, Ahmed R. Abu‐Raghif, Hayder Adnan Fawzi
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 23-42
Closed Access | Times Cited: 14
The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics
Yutao Lou, Xiaozhou Zou, Zongfu Pan, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 8, pp. 1018-1027
Closed Access | Times Cited: 14
The aging lung: microenvironment, mechanisms, and diseases
Yanmei Wang, Xuewen Huang, Guo‐Feng Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy
Jianying Qi, Yuanyuan Wu, Zhimou Guo, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132896-132896
Closed Access | Times Cited: 8
Diversity of group 1 innate lymphoid cells in human tissues
Natália Jaeger, Alina Ulezko Antonova, Daniel Kreisel, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1460-1473
Closed Access | Times Cited: 8
The proteasome-dependent degradation of ALKBH5 regulates ECM deposition in PM2.5 exposure-induced pulmonary fibrosis of mice
Yaling Zhang, Qingping Liu, Jie Ning, et al.
Journal of Hazardous Materials (2022) Vol. 432, pp. 128655-128655
Closed Access | Times Cited: 35
The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update
Xiaoshan Su, Weijing Wu, Zhixing Zhu, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
Yihang Zhang, Jiazhen Wang
Advances in respiratory medicine (2023) Vol. 91, Iss. 1, pp. 26-48
Open Access | Times Cited: 22
Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
Lorraine Thong, Enda James McElduff, Michael T. Henry
Life (2023) Vol. 13, Iss. 2, pp. 486-486
Open Access | Times Cited: 21
Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis
Jie Ji, Shudan Zheng, Yuxin Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Yahan Xu, Peixiang Lan, Tao Wang
Medicina (2023) Vol. 59, Iss. 11, pp. 1984-1984
Open Access | Times Cited: 18
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Nintedanib Mitigates Radiation-Induced Pulmonary Fibrosis by Suppressing Epithelial Cell Inflammatory Response and Inhibiting Fibroblast-to-Myofibroblast Transition
Jingyao Tu, Xinyi Chen, Chunya Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3353-3371
Open Access | Times Cited: 7
Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis
Giovanni Ligresti, Ahmed Raslan, Jeongmin Hong, et al.
Gene (2023) Vol. 859, pp. 147142-147142
Open Access | Times Cited: 15
Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis
Meng-chuan Wang
Heliyon (2023) Vol. 9, Iss. 8, pp. e19308-e19308
Open Access | Times Cited: 15
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Peng Pi, Zhipeng Zeng, Liqing Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions
Pritha Saha, Priti Talwar
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 9, pp. 2181-2194
Closed Access | Times Cited: 14
Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2
Yan Yang, Xinmeng Wang, Jie Zhang
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1128-1140
Open Access | Times Cited: 5
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways
Marjan Taherian, Paria Bayati, Nazanin Mojtabavi
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top